Rheumatoid arthritis trials in Serbia
3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
- Where
- Belgrade, Novi Sad
- Age
- 18 years to 75 years
- People
- 180 worldwide
- Run by
- Elevara Medicines Limited
See details and how to joinNCT07409103 - Phase 2Taking peopleA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Where
- Belgrade, Novi Sad
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- AbbVie
See details and how to joinNCT06972446 · EU 2025-520721-21-00 - Phase 2Taking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Belgrade
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00